Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New asthma treatment shows promise in Real-World study

NCT ID NCT06566885

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times

Summary

This study looks at how well tezepelumab works for people aged 12 and older with severe asthma in Russia. Over 52 weeks, researchers track changes in asthma control and symptoms using patient questionnaires. The goal is to understand the real-world benefits of this treatment for managing severe asthma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Research Site

    Kaliningrad, Russia

  • Research Site

    Kemerovo, Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Nal'chik, Russia

  • Research Site

    Nizhny Novgorod, Russia

  • Research Site

    Novosibirsk, Russia

  • Research Site

    Orenburg, Russia

  • Research Site

    Petrozavodsk, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Shelehov, Russia

  • Research Site

    Stavropol, Russia

  • Research Site

    Tomsk, Russia

  • Research Site

    Ulan-Ude, Russia

  • Research Site

    Yekaterinburg, Russia

Conditions

Explore the condition pages connected to this study.